Top 50 Life Science Startup Investors in France in July 2025
A list of 50 angel investors and VC (Venture Capital) funds that invest in Life science startups based in France. We rank investors based on the number of investments they made in Life science companies from France. We update this investor list every month.Top 50 Life Science Startup Investors in France in July 2025
Investor | Life Science France investments |
---|---|
Bpifrance | 13 |
Kurma Partners | 8 |
Omnes Capital | 6 |
Sofinnova Partners | 5 |
Seventure Partners | 5 |
Paca Investissement | 4 |
Idinvest Partners | 4 |
Boehringer Ingelheim Venture Fund | 3 |
Karista | 3 |
AdBio partners | 3 |
Galia Gestion | 3 |
Blue Horizon Corporation | 3 |
Advent Life Sciences | 2 |
Siparex Groupe | 2 |
Sylvain Zimmer | 2 |
Horizons Ventures | 2 |
Partech | 2 |
Sofimac Investment Managers | 2 |
JDRF T1D Fund | 2 |
Andrew Nutter | 2 |
Point Nine | 2 |
IRDI SORIDEC Gestion | 2 |
Invus | 2 |
Thia Ventures | 2 |
Eutopia VC | 2 |
WiSEED | 2 |
Alexandria Venture Investments | 2 |
Polytechnique Ventures | 2 |
Air Street Capital | 2 |
Beyond Impact | 2 |
Heartcore Capital | 2 |
Social Starts | 2 |
Kinled Holding | 2 |
AQUITI Gestion | 2 |
XAnge | 2 |
Sebastian Lombardo | 1 |
Meusinvest (Noshaq) | 1 |
Eli Lilly | 1 |
EIT Health | 1 |
Jacques Lewiner | 1 |
Gimv | 1 |
Sofipaca | 1 |
Earlybird Venture Capital | 1 |
Resonance | 1 |
Florac | 1 |
Shire | 1 |
Bioqube Ventures | 1 |
Banque Populaire Group | 1 |
ACG Management | 1 |
EIC-Fund | 1 |
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Funding Round, Series A
- France, United States, Switzerland
Portfolio highlights
- Animaj — Explore the future of storytelling where AI meets creativity at Animaj Lab. Join us on a journey to revolutionize kids' entertainment, crafting captivating content that keeps the digital-first generation engaged and inspired.
- Veesion — Veesion: AI-driven smart video surveillance. Detect theft in real time. Protect your business now.
- DejaBlue — The unified electrification offering for smarter, greener businesses.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Series A, Seed, Series B
- France, Switzerland, Spain
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.
Show more
Investment focus
- Biotechnology, Software, Health Care
- Series A, Funding Round, Series B
- France, Germany, United States
Portfolio highlights
- Planet A Foods — The chocolate revolution is here. 100% cocoa-free and unbelievably delicious. We call it QOA. You need to try it!
- VSORA — VSORA provides high performance companion solutions combining AI and signal processing to enable autonomous driving and ADAS
- Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- France, United States, United Kingdom
Portfolio highlights
- SafeHeal — SafeHeal is a clinical stage medical device manufacturer focusing on the development of anastomosis protection devices, including Colovac, for colorectal surgery.
- Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
- One Biosciences — One Biosciences unlocks routine analysis of tumor heterogeneity through AI-powered single-cell technologies, transforming precision medicine.
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today:
- Life Sciences : Biotech, Healthcare, Nutrition
- Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity
- Sports & Wellbeing
- Blue Economy
Show more
Investment focus
- Biotechnology, Health Care, Software
- Series A, Funding Round, Series B
- France, United States, Germany
Portfolio highlights
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- Reelevant — Only 1 out of 10 people interact with marketing messages. Content is the bottleneck of personalization, not data. Personalization doesn't work because data are used to create targeted campaigns. Data must be used to create content because content creates interactions and drive conversion.Why: create content for people, not for campaigns(visual is the key to emotions) How: on-demand, when the user request, at the opening/reading/exposure (Pull content vs Push marketing) What: end-to-end widgets solutions like Live content, Individualization, Content Automation, Optimization, etc.Our visual content platform accelerates revenue, creates content based on any data (behavioral, contextual, etc.) created on the fly at the moment of exposure (on any channel (email, web, push notifications, in-app messages, etc.). We take advantage of existing data sources, nothing to create, we supercharge your marketing stack. Our data-driven Content Engine translates data from any source into on-demand visual content in milliseconds for each people.We believe in a new way of thinking about messages by shifting the paradigm of push marketing to transform any data into on-demand visual content. One unique content is created for each people on the fly at the moment people decide to read them (pull content), instead of when marketers decide to create them (push marketing).People are not data points, people don't buy products, they buy emotions. On-demand visual content is the new game!
- Seaweed Concept — Seaweed Concept is a marine biotechnology company, that focuses on the innovative utilization of seaweed to provide high-quality ingredients to various industrial sectors
Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.
Show more
Investment focus
- Software, Internet, Manufacturing
- Seed, Funding Round, Series A
- France
Portfolio highlights
- GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
- SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
- C4Diagnostics — C4Diagnostics developed a fast, reliable detection of microorganisms. Our Click-chemistry technology is at the core of our portfolio of diagnostic tests.
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Series B, Series A, Funding Round
- France, United States, Spain
Portfolio highlights
- Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
- StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
- Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Germany, Belgium
Portfolio highlights
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
- Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.
Show more
Investment focus
- Software, Biotechnology, Health Care
- Seed, Series A, Series B
- France, United States, Finland
Portfolio highlights
- Deemea — Deemea is a collaborative AI platform that connects and provides services for the analysis of medical data for physicians. It uses its expertise in clinical research, data science, and software development to help healthcare professionals.
- 10Lines — 10Lines is developing autonomous parking lot marking robots and technological solutions to significantly increase productivity in the industry of pavement marking. Our solutions are helping striping businesses do their work much more productively with a smaller environmental footprint.
- Brightflow — Brightflow operates as a medical device startup.
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Seed, Series A, Funding Round
- France, Spain, Belgium
Portfolio highlights
- Cephagenix — Cephagenix focuses on identifying and developing new, effective migraine therapies.
- Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.
Show more
Investment focus
- Software, Manufacturing, Biotechnology
- Funding Round, Series A, Seed
- France, United States
Portfolio highlights
- Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
- Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
- Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.
Show more
Investment focus
- Food and Beverage, Food Processing, Biotechnology
- Seed, Series A, Pre-Seed
- United States, United Kingdom, Germany
Portfolio highlights
- WOW EARN — WOW EARN connects users to the blockchain, enabling them to mine, earn, and trade via decentralised mining, earning, and trading systems.
- EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
- foodforecast — AI supported solution to reduce food waste.
Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- United States, United Kingdom, France
Portfolio highlights
- Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
- Arga Medtech — Novel Sine Wave Technology Promises Significant Advantages Over Existing Pulsed Field Cardiac Ablation Systems
- Relief Cardiovascular — Relief Cardiovascular is an inQB8 medical technologies portfolio company developing a revolutionary smart implant to decongest heart failure patients.
Siparex, France,s first multi-sectoral private equity investment company, is founded in Lyon.It was a start-up at a time when the spirit of enterprise was flagging. It emerged in one of France's regions, listed the shares of the original company one of its main vehicles on the stock market, grew internationally, and has become one of theindependent groups in its line of business in the space of 30 years.
Show more
Investment focus
- Manufacturing, Software, Information Technology
- Private Equity, Funding Round, Seed
- France, United States, Italy
Portfolio highlights
- E-Recycle — E-Recycle is an online and offline store that specializes in recycling used high-tech products such as mobile phones, tablets, and PCs.
- NeoPhotonics — NeoPhotonics design and manufacture advanced hybrid photonic integrated optoelectronic devices for ultra-fast communications networks, including optical components
- Ekoscan Integrity — Ekoscan Integrity is an innovative solution for the integrity and sustainability of industrial products through the implementation of innovative technology.
Sylvain is a French software developer turned entrepreneur, conference organizer and angel investor.
Show more
Investment focus
- Software, Financial Services, SaaS
- Seed, Pre-Seed, Angel
- France, United States, United Kingdom
Portfolio highlights
- GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
- Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
- TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more
Investment focus
- Biotechnology, Artificial Intelligence, Software
- Series A, Series B, Seed
- United States, United Kingdom, Canada
Portfolio highlights
- Notpla — We are a combination of designers and chemists, engineers and entrepreneurs. We’re hard to define because what we’re doing hasn’t been done before. We create advanced packaging solutions that disappear, naturally.
- Owlstone Medical — Owlstone Medical has developed a breathalyzer for disease. With a focus on non-invasive diagnostics for cancer, inflammatory disease, and infectious disease, the company aims to save 100,000 lives and $1.5B in healthcare costs.The company’s Breath Biopsy® platform has introduced a new diagnostic modality making it possible to discover novelnon-invasive biomarkers in breath using a platform with the potential to transition to point-of-care. The award-winning ReCIVA Breath Sampler ensures a reliable collection of breath samples. The volatile organic compounds (VOCs) present in the breath are analyzed using proven microchip chemical sensor technology (FAIMS) to detect biomarkers of disease.The Breath Biopsy platform can be used in clinical diagnostics and precision medicine with applications in cancer and a wide range of other medical conditions. Highly sensitive and selective, these tests allow for early diagnosis when treatments are more effective and more lives can be saved.Owlstone Medical is currently developing tests for lung and colorectal cancer, two of the most common cancer killers worldwide, and for asthma stratification by the therapeutic response. The company also Breath Biopsy products and services to academic, clinical, and pharma partners who want to develop breath-based diagnostics for their own applications.
- Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.
Show more
Investment focus
- Software, E-Commerce, SaaS
- Series A, Seed, Series B
- United States, France, Germany
Portfolio highlights
- Enter — baupal seeks to democratize sustainable and customized architecture, making design, energy assessments, permitting and cost evaluations more accessible and straightforward for private builders and smaller construction projects. baupal is an online building application service that takes advantage of digital processes and efficient team structuresto streamline design, planning and permitting processes for a range of small-scale projects.baupal was established in December, 2020 in Berlin, Germany.
- Mercanis — Source services smarter and drive automation along your source-to-settle process. Discover how Mercanis enables you to collaborate with best-in-class suppliers across your departments.
- Makersite — AI, data and apps for procurement, product design and expert teams to make faster sustainable product and supply chain decisions, at scale.
Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)
Show more
Investment focus
- Biotechnology, Health Care, Manufacturing
- Funding Round, Seed, Series A
- France, Italy, Austria
Portfolio highlights
- Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
- Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
- Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Funding Round, Series B
- United States, France, Italy
Portfolio highlights
- vTv Therapeutics — vTv Therapeutics, a pharmaceutical company, focuses on the discovery and development of human therapeutics to fill unmet medical needs. Its mission is to utilize its innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines.vTv Therapeutics has a pipeline of small molecule clinicaland pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, metabolic disorders, inflammation, and cancer. The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts. The quality and breadth of vTv's product candidate pipeline, platform technology, scientific team, and strategic collaborations have enabled it to become a fully integrated pharmaceutical company.The company's commitment to drug discovery is reflected in its medical solutions and the many exciting potential new treatment options in its pipeline. The company's major R&D activities have focused on central nervous system disorders, metabolic disorders, inflammation and oncology.vTv Therapeutics is advancing several proprietary drug candidates. The company's lead candidate, azeliragon (aka TTP488), is a novel, orally bioavailable small molecule compound that is being developed for the treatment of Alzheimer's disease. In Phase 2 clinical trial in patients with mild to moderate Alzheimer's disease, azeliragon showed a statistically significant difference of more than 3 points in ADAS-cog at 18 months compared to placebo.Azeliragon has been granted Fast Track Designation and agreement on its Phase 3 protocol has been reached with FDA via a Special Protocol Assessment (SPA). The Phase 3 study in patients with mild Alzheimer's disease was initiated in April 2015 with a clear path forward to registration with the aim to demonstrate disease modification.vTv Therapeutics is also prosecuting the clinical development of TTP399, a novel functionally liver-selective Glucokinase Activator ("GKA") for the treatment of type 2 diabetes. In a Phase 2a study, TTP399 normalized patients' HbA1c without inducing hypoglycemia, after only six weeks of treatment. A six-month Phase 2 study is ongoing.
- Eledon Pharmaceuticals — Eledon Pharmaceuticals, Inc. is a clinical-stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease.
- Cour Pharmaceuticals Development — Reprogramming the immune system. Restoring lives.At COUR, we develop targeted therapies that incite calm within the immune system and help restore the healt ...
Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.
Show more
Investment focus
- Software, SaaS, Biotechnology
- Seed, Pre-Seed, Funding Round
- France, United Kingdom, United States
Portfolio highlights
- Yavin — Yavin provides modern point-of-sale solutions for European merchants
- Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
- EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
Point Nine Capital is a Berlin-based venture capital firm focused exclusively on early-stage Internet investments in areas like Software-as-a-Service (SaaS), online marketplaces, and mobile.The fund and its managers, Pawel Chudzinski and Christoph Janz have backed a number of highly successful Internet companies such as Delivery Hero, Clio,Shiftplanning, Vend, Typeform, and Zendesk from their earliest stages.
Show more
Investment focus
- Software, SaaS, Internet
- Seed, Series A, Series B
- Germany, United States, France
Portfolio highlights
- Aletiq — Aletiq is an online PLM software that offers technical data management solutions for industrial companies.
- sensmore — Equip your machinery with autonomy built for the harshest conditions. Enhance safety, reduce costs, and increase efficiency with our advanced radar technology.
- Rerun — Multimodal log handling and visualization for spatial and embodied AI. Managed infrastructure to ingest, store, analyze, and stream data at scale with built-in visual debugging. Fast, flexible, and easy to use.
IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Seed, Series A, Funding Round
- France, Brazil, Singapore
Portfolio highlights
- FEEDAE — Feedae uses AI-augmented dialog analysis to boost sales and customer service teams' performance.
- IsyBuy — IsyBuy is a smartphone application that allows to find restaurants and bars that have your way, consult the menu, place order, and still pay your bill directly from your cell phone, with just one click. It's the fastest, easiest, and safest way to borrow and pay. They will never have to wait to be served by a waiter, let alone beg to receivethe account or the card machine.
- Keysom — Develops RISC V based processor architectures that are automatically built from the application source code and dynamically reconfigurable.
Invus recognizes that every company is unique and that extraordinary business performance cannot be achieved by following a formulaic approach. Due to their unique structure, they have a great deal of flexibility in the types of companies and situations where they can get involved.They know that real transformation takes time and that it is nevera straight line. They fully align their incentives with their partners and have the wherewithal and long-term commitment to see through any bumps along the way.They have been successfully empowering owner-managers since 1985. They have been reinvesting the same pool of money from the same group of European families (through their Artal investment vehicle) since their founding. Today they manage over $4 billion in an evergreen fund and work out of offices in New York, London, Paris and Hong Kong.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series B, Series C, Series A
- United States, France, China
Portfolio highlights
- One Biosciences — One Biosciences unlocks routine analysis of tumor heterogeneity through AI-powered single-cell technologies, transforming precision medicine.
- GenSight Biologics — GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases. GenSight Biologics is a privately owned biopharmaceutical company, dedicated to the development and commercialization of gene therapy-based treatments of retinal degenerative diseases.Based on recent results obtained by the teams of its scientificfounders, the company develops innovative approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from very low vision or blindness.
- Edgewise Therapeutics — See how we bring our unique expertise and singular focus on muscle science to develop novel therapeutics for serious skeletal and cardiac muscle diseases.
WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team
Show more
Investment focus
- Biotechnology, Food and Beverage, Health Care
- Series A, Seed, Series B
- United States, France, Denmark
Portfolio highlights
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- Protealis — Sustainable plant proteins for Europe
- Switch Bioworks — Switch Bioworks engineers symbiotic microbes to produce sustainable nitrogen fertilizer under the control of precise genetic circuits.
Eutopia is a fund for consumer startups. We back founders who are rethinking the way we eat, shop, sleep and feel. We are backing 26 startups
Show more
Investment focus
- Retail, E-Commerce, Food and Beverage
- Seed, Series A, Funding Round
- France, Belgium, Denmark
Portfolio highlights
- GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
- Bastille — Bastille is a brand of urban bicycles. The Astir brand is synonymous with folding bicycles. The primary quality constraint Bastille, a British designer, aims to create a folding motorcycle with standard wheels rather than the mini 16-inch wheels that are traditionally associated with folding bikes.
- SPRiNG Collective — SPRiNG is a consumer goods company that offers clean and efficient laundry and cleaning products, delivered in a 100% plastic-free box and directly in the mailbox. The company is headquartered in Paris, Ile-de-France, France by Philippe Cantet, Laure Favre, and Ben Guerville in 2017.
Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.
Show more
Investment focus
- Software, Manufacturing, Biotechnology
- Seed, Funding Round, Equity Crowdfunding
- France
Portfolio highlights
- Leasi — Leasi delivers a forward-thinking rental and resource management system for companies that engage in internal or external distribution of machinery. This is achieved through an ecosystem that emphasizes the excessive use of data and datasharing, with a focus on user experience. Our goal is to create a simpler, more streamlined, and more efficientworkday for industry players by leveraging the power of data and collaboration within the ecosystem to ultimately reduce emissions, increase efficiency and enhance profitability.
- Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
- Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, Canada, France
Portfolio highlights
- Remedy Plan Therapeutics — Remedy Plan is a biotechnology company developing the first drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis.
- HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
- GeneCentric Therapeutics — GeneCentric Therapeutics engages in developing and commercializing molecular diagnostic tests for oncologists and patients. The company currently has two unique platform technologies including The Lung Subtype Platform (LSP) stratifies lung cancer patients into subtypes, which are important for appropriate therapeutic selection. The firstapplication of LSP was licensed to and independently developed by Laboratory Corporation of America Holdings (“LabCorp”) and is now available through its specialty testing business, Integrated Oncology, as HistoPlusSM: Lung Cancer. Its second platform technology is the Hypoxia Signature which has the potential to identify patients that respond to anti-angiogenesis therapies.GeneCentric utilizes a unique partnership model to translate important cancer discoveries into clinically adopted diagnostics for pathologists, clinicians, and, most importantly, patients. The company was incorporated in 2011 and is based in Durham, North Carolina.
Polytechnique Ventures support entrepreneurs from the School's ecosystem.
Show more
Investment focus
- Energy, Renewable Energy, Apps
- Seed, Pre-Seed, Funding Round
- France, United Kingdom
Portfolio highlights
- PACT — PACT designs Elegant materials produced in tune with the planet earth. It create revolutionary, sustainable biomaterials using the earth's resources, including collagen, herbal extracts, oils, and minerals.
- Descartes & Mauss — Home - Your Next Best Move, at Scale, Every Day: Meet the first AI-powered growth strategy platform
- One Biosciences — One Biosciences unlocks routine analysis of tumor heterogeneity through AI-powered single-cell technologies, transforming precision medicine.
Air Street Capital invests in AI-first companies.
Show more
Investment focus
- Artificial Intelligence, Machine Learning, Biotechnology
- Seed, Series A, Pre-Seed
- United States, United Kingdom, Canada
Portfolio highlights
- Sereact — Discover the world's easiest pick and place automation solution. Significant cost savings, productive 24/7, deployment in one day and no training required.
- Fern Labs — Deploying agents at the scale of real world problems
- Hedera Dx — A diagnostics platform that makes liquid biopsies a reality in cancer care
Beyond Impact is your trusted Managed Service Provider (MSP), delivering tailored IT solutions like managed IT services, cybersecurity, cloud computing, IT help desk support, and data backup. Our expert team aligns your IT with business goals, providing proactive monitoring and network security. Contact us today to streamline your IT operations for a secure, agile, and future-ready business. Beyond Impact: Empowering your IT success.
Show more
Investment focus
- Food and Beverage, News, Seafood
- Seed, Series A, Pre-Seed
- France, Canada, Singapore
Portfolio highlights
- GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
- Nowadays — The Nowadays nugget is made with just 7 simple, plant-based ingredients.
- SEAFOOD REBOOT — Seafood Reboot's ambition is to promote worldwide best-in-class Fish substitutes from micro-algae for natural, healthy, sustainable food and to preserve marine wildlife.
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more
Investment focus
- Software, FinTech, Artificial Intelligence
- Seed, Series A, Series B
- Denmark, United States, Germany
Portfolio highlights
- PhaseTree — Materials design simulation company - PhaseTree ApS
- Veda — Veda is the largest vault infrastructure platform in DeFi, enabling institutions to launch and manage onchain financial products at scale.
- Superform Labs — THE UNIVERSAL INTERFACE FOR YIELD IS FORMING
Social Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds.
Show more
Investment focus
- Software, Health Care, Artificial Intelligence
- Seed, Series A, Funding Round
- United States, Germany, United Kingdom
Portfolio highlights
- Hey Jane — Get safe, effective and affordable abortion pills delivered fast to your home. Hey Jane is the first digital abortion clinic, connecting you to licensed providers in your state through telemedicine.
- Mae Health — Mae is a maternal health platform that connects expectant mothers with critical resources to drive positive pregnancy outcomes.
- Wayfinder Biosciences — We design RNA for next generation biomanufacturing and smart therapeutics.
Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more
Investment focus
- Biotechnology, Health Care, Financial Services
- Seed, Funding Round, Series A
- United Kingdom, United States, Switzerland
Portfolio highlights
- Xapien — Xapien delivers automated insight reports on companies and individuals in minutes, so you can make informed business decisions quickly and with confidence.
- OneTrust — OneTrust is a provider of privacy management and marketing compliance technology that helps organizations comply with global regulations. It automates privacy impact assessments and data inventory mapping, enforces risk remediation actions, and triggers recurring audits for continuous compliance monitoring across customer, employee, and vendor datatransfers. Its web-based software can be accessed on any device and provides a single place for a private office to collaborate with business groups, vendors, and trusted advisors managing privacy risks. The result is the ability to demonstrate privacy by design and ongoing compliance with policies, data privacy laws (GDPR, BCR, Privacy Shield), and other privacy frameworks (HITECH, ISO, GAPP, APEC).The company was founded in 2016 and is headquartered in Atlanta, Georgia.
- Connect Earth — Connect Earth is an environmental data company that builds the infrastructure for climate-conscious products by aggregating and standardising environmental data and making it available through developer-first toolkits. The core product is an API solution that calculates the carbon impact of spend-based financial transactions of consumers and companies.
Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.
Show more
Investment focus
- Biotechnology, Software, Manufacturing
- Funding Round, Series A, Seed
- France, United States
Portfolio highlights
- Speeral — Speeral is a technological solution for user to access second-hand market and products.
- Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
- Materrup — Materrup produces low-carbon earth concrete for construction and urban development. Materrup construction solutions meet the requirements of future RE2020 regulations and the urgent need to reduce the carbon footprint of the construction industry.
XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.
Show more
Investment focus
- Software, Information Technology, SaaS
- Series A, Seed, Series B
- France, Germany, Belgium
Portfolio highlights
- Animaj — Explore the future of storytelling where AI meets creativity at Animaj Lab. Join us on a journey to revolutionize kids' entertainment, crafting captivating content that keeps the digital-first generation engaged and inspired.
- Ensweet — Ensweet is a telemedicine platform intended to offer telerehabilitation services to patients. They offer equipment so that everyone can exercise whenever possible, enabling patients to have accessible rehabilitation.
- Diagnoly — Diagnoly provides AI-powered ultrasound assistant that enhances fetal screenings with real-time analysis, instant insights, and zero workflow disruption.
Sebastian Lombardo - CEO @ Valtech
Show more
Investment focus
- Apps, Internet, Lifestyle
- Seed
- France, United States
Portfolio highlights
- Jop — A one-stop-shop for urban residents, Jop offers a variety of on-demand services in one convenient, easy-to-use platform. Customers can tap a screen and connect with a professional in their city, whether they are an expert at cleaning apartments, trimming mustaches, walking dogs, doing makeup, DJing, or mixing drinks. Instead of paying a company’soverhead, customers pay a Jopper. Once booked, Joppers arrive right at the customer’s doorstep, ready to work.Founded by Canel Frichet and Sebastian Lombardo, Jop was born as a platform to give people the opportunity to work directly for each other, as opposed to hiring through a company. Joppers set their own pricing and hours. Something else that sets JOP apart from other platforms in the on-demand space is that Joppers earn company equity, which is granted based on level of activity and performance on the platform.
- Smart Immune — Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change the prognosis and life quality of patients with devastating diseases. The company's first cell therapy program is based on T cell progenitors or ProTcellsTM (CD7+/CD34-; CD5- cells)curative power to enable a short, polyclonal, and safe post-transplantation immune recovery. This program be completed by integrative developments from targeted conditioning to gene therapy and genome editing enabling clinicians to access new-generation treatments for a wide variety of inherited blood disorders and blood cancers.
Noshaq offers financial services to help businesses develop.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Funding Round
- Belgium, France, Germany
Portfolio highlights
- TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
- Veoware — More coverage, shorter revisit time. Increasing target collection frequency through modular next-gen actuator technology.
- Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conductsresearch to find products to treat diseases in animals and to increase the efficiency of animal food production.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Funding Round
- United States, United Kingdom, Canada
Portfolio highlights
- Therini Bio — Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
- Signify Bio — Signify Bio combines the promise of signal peptide engineered control with the speed and power of mRNA encoded design.
- Stylus Medicine — Stylus Medicine, Inc. is a biotechnology company dedicated to developing transformative in vivo genetic medicines.
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more
Investment focus
- Health Care, Medical Device, Medical
- Grant, Pre-Seed, Seed
- United Kingdom, Spain, Ireland
Portfolio highlights
- IDOVEN — IDoven develops products to detect heart problems at an early stage to prevent heart diseases.
- eBreathie — eBreathie is a pioneering digital health startup offering an integrated asthma management solution. Our system comprises a smart inhaler (a medical device) that not only tracks WHEN patients take their medication but also HOW they do it, creating a detailed inhalation profile for each use. Paired with a user-friendly mobile app for patients and acomprehensive patient management platform for doctors, we provide real-time feedback on inhalation efficacy, ensuring patients and healthcare professionals have the insights needed for optimal asthma management. Leveraging IoT and AI, our goal is to reduce emergency visits, asthma attacks, and hospitalizations while ensuring effective inhalation techniques and optimal patient care.
- Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Jacques Lewiner - Member of the Board of Directors @ Axilum Robotics
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Seed, Series C
- France
Portfolio highlights
- Cytoo — CYTOO focuses on innovative products for the life science research market with an emphasis in cell based assays, high content analysis and cell screening.They develop, manufacture, and distribute products that make cellular analysis robust and reliable by dramatically decreasing cell variability.There new micropattern-based products aredesigned to meet the needs of all clients whatever their research goals. They are open to suggestions or specific requests that can improve and spread the scope of this breakthrough in quantitative cell analysis.
- Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
Gimv, a trusted European investment company, helps mid-market businesses create sustainable value through growth capital and expertise across diverse sectors.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Funding Round, Private Equity
- Belgium, United States, France
Portfolio highlights
- Curana — Curana is a manufacturer of bike equipment and accessories.
- Kivu Bioscience — At Kivu Bioscience, we leverage advanced, next-generation proprietary ADC technologies to deliver more precise and effective cancer treatments.
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Sofipaca supports SMEs and mid-caps in the SOUTH region in the long term in their development capital and transmission capital operations.
The company was founded in 1984 and based in Aix en Provence, France.
Show more
Investment focus
- Food and Beverage, Pharmaceutical, Manufacturing
- Private Equity, Series A, Series B
- France
Portfolio highlights
- HalioDx — Veracyte translates the tumor immune response into clear insights to guide treatment decisions, inform biomarker development, or advance therapeutics.
- Cintoo — Cintoo is essential for BIM to bridge the gap between your physical and virtual worlds.
- Keep Cool — Keep Cool is a operator of a chain of fitness centers.
Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.
Show more
Investment focus
- Software, Information Technology, Health Care
- Series A, Seed, Series B
- Germany, United States, United Kingdom
Portfolio highlights
- TopK — TopK features native support for both vector search and keyword search in a single, unified system. With its powerful query expression language, TopK enables you to build reliable search applications (semantic search, RAG, multi-modal, you name it) without juggling multiple databases or services. Our unified retrieval engine will evolve tosupport document transformation, query understanding (parse metadata filters from user query), and adaptive ranking (provide more relevant results by sending “relevance feedback” back to TopK) under one roof.
- Arago — Arago is an AI and computer hardware company developing an energy-efficient AI chip powered by light, and its associated software.
- Portal Biotech — Portal has created next generation solutions that address the significant opportunities in protein sequencing and metabolomics
We are on your frequency - Resonance partners with early-stage founders, helping them to shake up their industry.
Show more
Investment focus
- Software, Information Services, B2C
- Series A, Pre-Seed, Seed
- France, United Kingdom, United Arab Emirates
Portfolio highlights
- Animaj — Explore the future of storytelling where AI meets creativity at Animaj Lab. Join us on a journey to revolutionize kids' entertainment, crafting captivating content that keeps the digital-first generation engaged and inspired.
- Tomorro (ex Leeway) — Leeway helps you reduce the time spent on contract management and gives you more control and visibility over legal and financial risks.
- Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
Florac is a mid-market investment firm that invests and supports management teams with defensible market-leading positions.It invests in single amounts in equity and quasi-equity with a flexible exit horizon alongside founders, managers, and strategic partners in companies with strong development potential and managed by excellent managementteams. The firm is wholly-owned by the Meyer family and investing only funds of the family.Léopold Meyer headquartered the firm in Paris, Ile-de-France in 2009.
Show more
Investment focus
- Sales, E-Commerce, Health Care
- Series A, Private Equity
- France
Portfolio highlights
- DocCity — DocCity LifeSciences creates and provides outstanding spaces to house cutting-edge healthcare businesses. DocCity provides clinicians with state-of-the-art, fully furnished health spaces with roomy, well-lit, and digitally equipped consultation rooms and reception areas.
- Clubfunding — ClubFunding is a crowdfunding platform. They offer small to medium-sized enterprises assistance in finding alternative financing from assets, individuals, and institutions.
- Bricoprivé.com — Bricoprive.com runs a dozen daily flash sales offering a wide range of professional-quality products to its six million members. On the back of a strong value proposition, unrivalled expertise in sourcing quality products in partnership with suppliers and solid digital experience, the company has evolved to become one of the leaders in the sector.
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.
Show more
Investment focus
- Biotechnology, Therapeutics, Biopharma
- Series C, Series B, Series A
- United States, France, Belgium
Portfolio highlights
- Naurex — Naurex Inc. is a clinical-stage company developing novel therapies for depression and other CNS disorders based on a new mechanism of action for modulating the N-methyl-D-aspartic acid receptor (NMDAR). Using these discoveries, Naurex researchers have generated novel chemical drug classes known as glycine-site functional partial agonists (GFPAs),which modulate the receptor in a different way than existing NMDAR agents. The company's drug development programs based on its GFPA NMDAR modulators include the first-generation molecule, GLYX-13, the second-generation NRX-1050 small molecule series and additional compounds from Naurex's platform of novel NMDAR modulators.
- Rani Therapeutics — Rani is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics, which we believe will have the potential to transform medicine and improve patient outcomes. We have developed the RaniPill capsule, which is our novel, proprietary and patented platform technology, intended to replacesubcutaneous or IV injection of biologics with oral dosing. The RaniPill capsule is an orally ingestible pill approximately the size of a “000” capsule (or similar to the size of a standard fish oil or calcium pill) that is designed to automatically administer a precise therapeutic dose of medication upon deployment in the small intestine. To date, we have successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using the RaniPill capsule. Our development efforts have enabled us to construct an extensive intellectual property portfolio that we believe provides us a competitive advantage.
- Promethera Biosciences — Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology.Promethera® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way usingallogenic progenitor cells from healthy human livers.Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):
A life science venture capital fund - investing globally in exciting science to accelerate breakthrough therapies in patients.
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Seed, Series B
- United States, France, Ireland
Portfolio highlights
- Enhanc3D Genomics — Enhanc3D Genomics is a spinout company from Babraham Institute.
- SynOx Therapeutics — SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors. SynOx Therapeutics raises EUR 37m to develop emactuzumab to improve the lives of patients with tenosynovial giant cell tumors November 16, 2020. It was founded in 2020 and is located in Dublin City, Ireland.
- Bicara Therapeutics — At Bicara, we are attacking cancer head-on by combining the precision of targeted therapies with the power of tumor-microenvironment modulators to create better medicines for patients.
Banque Populaire Group provides banking and credit services for individuals, international and corporate.
Show more
Investment focus
- Manufacturing, Energy, Software
- Seed, Pre-Seed, Funding Round
- France
Portfolio highlights
- ATAWEY — Founded in 2012 by Jean-Michel Amaré and Pierre-Jean Bonnefond, ATAWEY designs and manufactures turnkey autonomous energy solutions for isolated sites. The entrepreneurs and their teams use mature, tried and tested French technologies to offer you an innovative, reliable and sustainable product. They build on their expertise to give you more than asimple response: a solution that adapts to your uses.The teams are well aware of the importance and the challenges of a source of energy on isolated sites, ATAWEY guarantees you support and a tailor-made service. They take full responsibility for the management of each project for optimal adaptability and reliability, economic relevance with a fast return on investment, all with the greatest respect for the environment.
- Quotelo — Quotelo creates an automatization system for hoteliers to regain commercial independence in the hospitality industry and digitizes group-event-seminar reservations. The company's platform centralizes all requests and reservations for groups, events, and seminars for any type of establishment by adding a graphical chatbot to each hotel'swebsite and collecting MICE and group requests from customers automatically generating commercial proposals and reserving the rooms, restaurants, activities, and nights requested, allowing hotels to book seminars, meetings, or even events online and improve productivity, responsiveness, image, and predictability.
- Meccellis Biotech — Meccellis Biotech is a manufacturer of tissue and cell and biomaterials.
Smalt Capital anciennement ACG Management, est un acteur majeur depuis plus de 20 ans
Show more
Investment focus
- Software, Health Care, Biotechnology
- Funding Round, Seed, Series A
- France, Madagascar
Portfolio highlights
- Kamp'n — Partenaire de croissance Facebook Ads & Google Ads
- Little Cigogne — Little Cigogne is reinvents the shopping experience for children.
- My Coach Football — My Coach Football allows you to manage and organize the daily operations of your football team, day after day, season after season. Designed to answer amateur and professional coaches’ needs, the platform centralizes all of your squad’s information and allows to gain time and efficiency. In a single click, you can manage players and their personalinformation, the preparation of training and games, but also individual and collective statistics. Season after season, you keep all those data and hence enjoy an optimum tracking of your team’s progression.
EIC offers investors the opportunity to co-invest in the most innovative start-ups and SMEs in the EU
Show more
Investment focus
- Information Technology, Health Care, Software
- Seed, Grant, Series A
- France, Turkey
Portfolio highlights
- EyeLights — EyeLights is a Head Up Display GPS. It allows motobikers to truly experience the ride by keeping their eyes on the road. Eyelights is the first universal motorcycle accessory that projects guidance, danger zones and traffic directly into your field of vision. A dangerous bend, a nearby stopper or speed over limitations, EyeLights warns you. Simple,uncluttered, they adapted the display for motorcycle riding.The EyeLights product installs in less than 5 minutes on your full-face, convertible or jet helmet. Their compact optical technology allows you to view your GPS more than 2 meters away while enjoying audio functions for more than 8 hours. The product is compatible with sun visors, insensitive to rain or fog and weighs less than 100g.
- Mistikist — Meet Mistikist, the best mindfulness app that helps you sleep, relax, focus and break the habit of being yourself in 2-8 minutes.
- Smart Immune — Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change the prognosis and life quality of patients with devastating diseases. The company's first cell therapy program is based on T cell progenitors or ProTcellsTM (CD7+/CD34-; CD5- cells)curative power to enable a short, polyclonal, and safe post-transplantation immune recovery. This program be completed by integrative developments from targeted conditioning to gene therapy and genome editing enabling clinicians to access new-generation treatments for a wide variety of inherited blood disorders and blood cancers.
Investors by industry
Consumer
Proptech
Impact
Climate
Gaming
Biotech
FinTech
Marketplace
Community
Health Care
Hardware
Energy
Artificial intelligence
Google
EdTech
Sustainability
Venture Capital
Real Estate
Photography
Clean Energy
Education
B2B
Financial Services
Big Data
Payments
Finance
Organic Food
Food and Beverage
Music
Art
Wellness
Web3
Franchise
Mobile
Local
Digital Media
Legal
Infrastructure
Android
eSports
Enterprise Software
Sports
Manufacturing
Retail
Email
Medical
Social Network
Social Media
Internet
Beauty
Construction
Hospitality
Platforms
Publishing
Biotechnology
Cannabis
Mobile Advertising
Travel
Video Games
Fitness
Recruiting
Crowdfunding
CleanTech
Social
Medical Device
Automotive
Wine And Spirits
Mobile Apps
InsurTech
Transportation
Enterprise
Life Science
LGBT
Fashion
Oil and Gas
Theatre
Film
Renewable Energy
Non Profit
SaaS
Sporting Goods
Restaurants
Celebrity
Software
Social Impact
Machine Learning
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Canada
Germany
United Kingdom
Ireland
South Korea
India
Australia
New Zealand
United States
Middle East
Brazil
LATAM
Qatar
Indonesia
Asia
Europe
Spain
South Africa
Singapore
Armenia
Saudi Arabia
Sri Lanka
China
Africa
Oceania
Japan
Vietnam
Belarus
Chile
Belgium
Hong Kong
Finland
Ghana
Georgia
Ethiopia
Gibraltar
Faroe Islands
Denmark
Egypt
Estonia
Costa Rica
Hungary
Greece
Barbados
Croatia
Belize
Bahrain
Czech Republic
Algeria
Ecuador
Bulgaria
Bermuda
France
Kuwait
Malta
Morocco
Nicaragua
Mali
Lithuania
Peru
Lebanon
Jersey
Norway
Myanmar
Mauritius
Liberia
Mexico
Malaysia
Liechtenstein
Poland
Philippines
Senegal
Sierra Leone
Tunisia
Togo
Serbia
Turkey
San Marino
Thailand
Italy
Uzbekistan
Taiwan
Sweden
Tanzania
Slovenia
El Salvador
Portugal
Tajikistan
Ukraine
Puerto Rico
Uganda
Venezuela
Uruguay
Zambia
Zimbabwe
Rwanda
Russian Federation
Dominican Republic
Israel
Panama
Nigeria
Iraq
Azerbaijan
Bahamas
Iceland
Namibia
Jamaica
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Albania
Pakistan
Grenada
Jordan
Bangladesh
Argentina
Romania
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cameroon
Latvia
Cyprus
Oman
Austria
Switzerland
Colombia
Guatemala
Marshall Islands
Seychelles
Investors in France by industry
Film
Transportation
Oil and Gas
Crowdfunding
Financial Services
Venture Capital
Beauty
Restaurants
Finance
Food and Beverage
Video Games
Wine And Spirits
Big Data
Medical
Software
Wellness
Medical Device
Mobile Advertising
Internet
Social Media
Digital Media
Manufacturing
Art
Android
Mobile
Blockchain
Non Profit
Legal
eSports
Sports
Enterprise Software
Travel
Automotive
CleanTech
Payments
Cannabis
Platforms
Biotechnology
FinTech
Consumer
Health Care
Enterprise
Hospitality
Biotech
EdTech
Climate
Energy
Sustainability
Proptech
SaaS
Marketplace
Artificial intelligence
Community
Hardware
Gaming
Retail
Mobile Apps
Infrastructure
Social
Fashion
Web3
Sporting Goods
Publishing
Clean Energy
Cryptocurrency
Renewable Energy
Fitness
Music
Real Estate
Life Science
Organic Food
InsurTech
Impact
Construction
B2B
Social Impact
Social Network
Media (entertainment)
Agriculture (agtech)
Education
Machine Learning
Email
Recruiting
Photography